Reprint

Asthma and Allergic Inflammation: Risks, Mechanisms, and New Treatments

Edited by
October 2021
142 pages
  • ISBN978-3-0365-2141-1 (Hardback)
  • ISBN978-3-0365-2142-8 (PDF)

This book is a reprint of the Special Issue Asthma and Allergic Inflammation: Risks, Mechanisms, and New Treatments that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Asthma is a multifaceted and puzzling disease. In the present book, well-known scholars offer their expert opinions and revise aspects of our current knowledge of this disease. Using new data (available in the upcoming Global Asthma Network study) on the epidemiology of asthma to explore the everlasting ‘chicken-or-egg’ conundrum,  the authors present clear information on topics such as new biological treatments, new approaches to inhalation combination therapy or sublingual immunotherapy, and present an in-depth exploration of old and new risk factors related to the novel epidemics of non-communicable diseases such as obesity. Regarding the ‘chicken-or-egg’ conundrum, the book offers some information on asthma inception and how this could relate to early lung development. Both editors are grateful for the time and effort that the authors have put into this project, and hope that this book will help healthcare providers to gain a better understanding of this complex disease.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
SABA overuse; systemic steroid overuse; asthma control; mild asthma; ICS adherence; treatment; exacerbation; airway eosinophilia; blood eosinophil count; omalizumab; mepolizumab; exhaled nitric oxide; induced sputum; allergic sensitization; asthma; rhinitis; allergy; allergic sensitization; genomics; epigenetics; hygiene hypothesis; allergic march; gene/environment interactions; personalized medicine; estradiol; severe asthma; postmenopausal asthma; sputum; Western lifestyle; saturated fats; simple carbohydrates; obesity; adipose tissue; inflammation; asthma; pre-school asthma; preterm newborn; infant lung function; asthma; children; efficacy; house dust mite; pollen allergy; rhinitis; safety; sublingual immunotherapy; asthma; epidemiology; cohort; latent transition analysis; comorbidities; smoke; vehicular traffic; global; asthma; surveillance; responses; children; adults’ epidemiology; inhaled corticosteroids; non-CF bronchiectasis; asthma; children; n/a